DIFFERENTIATION OF MYELOID LEUKEMIC-CELLS INDUCED BY HIGH-DOSE METHYLPREDNISOLONE IN PATIENTS WITH ACUTE MYELOBLASTIC-LEUKEMIA AND ITS THERAPEUTIC POTENTIAL

被引：31
|
作者：
HICSONMEZ, G
OZSOYLU, S
TUNCER, AM
机构：
[1] Department of Pediatric Hematology, Hacettepe University, Faculty of Medicine
来源：
LEUKEMIA RESEARCH | 1991年 / 15卷 / 07期
关键词：
DIFFERENTIATION THERAPY; HIGH-DOSE METHYLPREDNISOLONE; ACUTE MYELOBLASTIC LEUKEMIA; CHILDREN;
D O I：
10.1016/0145-2126(91)90020-T
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：537 / 541
页数：5
相关论文
共 50 条
  • [21] MODULATION OF CELL-PROLIFERATION AND CYTOKINE PRODUCTION IN ACUTE MYELOBLASTIC-LEUKEMIA BY INTERLEUKIN-1 RECEPTOR ANTAGONIST AND LACK OF ITS EXPRESSION BY LEUKEMIC-CELLS
    RAMBALDI, A
    TORCIA, M
    BETTONI, S
    VANNIER, E
    BARBUI, T
    SHAW, AR
    DINARELLO, CA
    COZZOLINO, F
    BLOOD, 1991, 78 (12) : 3248 - 3253
  • [22] The role of short course of high-dose methylprednisolone in children with acute myeloblastic leukemia (FAB M2) presented with myeloid tumor
    Hiçsönmez, G
    Çetin, M
    Aslan, D
    Özyürek, E
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2003, 20 (05) : 373 - 379
  • [23] IN-VIVO ACCUMULATION OF ETOPOSIDE IN PERIPHERAL LEUKEMIC-CELLS IN PATIENTS TREATED FOR ACUTE MYELOBLASTIC-LEUKEMIA - RELATION TO PLASMA-CONCENTRATIONS AND PROTEIN-BINDING
    LILIEMARK, EK
    LILIEMARK, J
    PETTERSSON, B
    GRUBER, A
    BJORKHOLM, M
    PETERSON, C
    LEUKEMIA & LYMPHOMA, 1993, 10 (4-5) : 323 - 328
  • [24] THE EFFECT OF HIGH-DOSE METHYLPREDNISOLINE ON CD34 - POSITIVE BONE-MARROW CELLS IN CHILDREN WITH ACUTE MYELOBLASTIC-LEUKEMIA
    TUNCER, AM
    HICSONMEZ, G
    GUMRUK, F
    ALBAYRAK, D
    DURU, F
    GUZEL, E
    SAYLI, T
    TURKISH JOURNAL OF PEDIATRICS, 1995, 37 (04) : 345 - 349
  • [25] High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
    Lowenberg, Bob
    Ossenkoppele, Gert J.
    van Putten, Wim
    Schouten, Harry C.
    Graux, Carlos
    Ferrant, Augustin
    Sonneveld, Pieter
    Maertens, Johan
    Jongen-Lavrencic, Mojca
    von Lilienfeld-Toal, Marie
    Biemond, Bart J.
    Vellenga, Edo
    Kooy, Marinus van Marwijk
    Verdonck, Leo F.
    Beck, Joachim
    Doehner, Hartmut
    Gratwohl, Alois
    Pabst, Thomas
    Verhoef, Gregor
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13): : 1235 - 1248
  • [26] Successful use of short-course high-dose methylprednisolone in a child with acute myeloblastic leukemia (FAB M2) and myeloid tumor
    Ozyurek, Emel
    Alioglu, Bulent
    Coskun, Mehmet
    Ozbek, Namik
    LEUKEMIA & LYMPHOMA, 2006, 47 (05) : 923 - 925
  • [27] A novel approach to treatment with high-dose steroid as a differentiation inducer in children with acute myeloblastic leukemia
    Hiçsönmez, G
    PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE, 2000, 19 (04): : 251 - 259
  • [28] EFFECT OF HIGH-DOSE BUSULFAN ON LEUKEMIC PROGENITOR CELLS IN CHRONIC MYELOID-LEUKEMIA
    MORSTYN, G
    SULLIVAN, J
    FAIRHEAD, S
    COWLING, D
    HURLEY, T
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1981, 11 (06): : 609 - 614
  • [29] RELAPSE OF ACUTE MYELOBLASTIC-LEUKEMIA LASTING FOR 4 YEARS - PRODUCTION BY LEUKEMIC-CELLS OF COLONY-STIMULATING ACTIVITY AND NON-PRODUCTION OF LEUKEMIA-ASSOCIATED INHIBITOR
    GIANNOULIS, N
    REIZENSTEIN, P
    OST, A
    ACTA MEDICA SCANDINAVICA, 1981, 210 (1-2): : 139 - 143
  • [30] Myeloprotective effect of short-course high-dose methylprednisolone treatment before consolidation therapy in children with acute myeloblastic leukemia
    Aytaç-Elmas, S
    Çetin, M
    Tuncer, M
    Hiçsönmez, G
    AMERICAN JOURNAL OF HEMATOLOGY, 2005, 80 (01) : 1 - 5
12345